BioMed Ventures
26
34M
18
2.00
1
0.31
9
- Stages of investment
- Areas of investment
Summary
BioMed Ventures is the famous VC, which was founded in 2010. The main department of described VC is located in the San Diego. The company was established in North America in United States.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the BioMed Ventures, startups are often financed by Valley Ventures, Solstice Capital, Clarus Ventures. The meaningful sponsors for the fund in investment in the same round are New Enterprise Associates, Sofinnova Investments, Solas BioVentures. In the next rounds fund is usually obtained by Solas BioVentures, Sofinnova Investments, Silicon Valley Bank.
Considering the real fund results, this VC is 15 percentage points less often commits exit comparing to other organizations. Comparing to the other companies, this BioMed Ventures performs on 11 percentage points more the average number of lead investments. The high activity for fund was in 2015. The increased amount of exits for fund were in 2015. Deals in the range of 10 - 50 millions dollars are the general things for fund. The average startup value when the investment from BioMed Ventures is 50-100 millions dollars. The fund is generally included in less than 2 deals every year.
The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Medical Device, Health Care. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Auspex Pharmaceuticals, Genalyte, Compass Therapeutics For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Investments analytics
Analytics
- Total investments
- 26
- Lead investments
- 1
- Exits
- 9
- Rounds per year
- 2.00
- Follow on index
- 0.31
- Investments by industry
- Biotechnology (24)
- Health Care (16)
- Medical (14)
- Therapeutics (4)
- Pharmaceutical (4) Show 13 more
- Investments by region
-
- United States (25)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Group Appearance index
- 1.00
- Avg. company exit year
- 14
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Compass Therapeutics | 12 Jul 2018 | Biotechnology, Therapeutics, Biopharma | Early Stage Venture | 49M | United States, Massachusetts, Boston |
| Histogenics | 23 Jul 2012 | Biotechnology, Health Care, Medical | Early Stage Venture | 49M | United States, Massachusetts |
| M-hospitality | 14 Nov 2018 | Information Technology, Mobile, Apps, Hospitality | Seed | 472K | Attica, Athens, Greece |
| Xinlianxin Intelligent Technology | 23 Apr 2021 | Product Design, Computer, Hardware, Application Specific Integrated Circuit (ASIC) | Seed | Shanghai, Shanghai, China |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.